Latin America Continuous Glucose Monitoring Device Market, By Component (Transmitters, Receivers, Insulin Pump, and Sensors ), by Distribution Channel (Hospitals & Clinics, Retail Channel, and Online Channel), and by Country (Mexico, Argentina, Uruguay, Brazil Colombia, Chile, Peru, and Rest of Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

  • Published On : Aug 2019 |
  • Pages : 161 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Latin America Continuous Glucose Monitoring Device - Market Insights

Continuous glucose monitoring devices have the potential to improve clinical outcomes for avoiding hypo/hyperglycemic events, an outcome of uncontrolled diabetes, which can arise due to skipped insulin dose. The currently available CGM devices display the glucose level and the magnitude and direction of changing glucose levels, thus becoming a vital tool to predict the forthcoming events of hypo- and hyperglycemia. Moreover, the device is more convenient for type 1 diabetic patients, as it requires continuous monitoring of glucose for administration of insulin on regular basis. Thus, use and benefits of CGM device in controlling both type 1 diabetes and hypoglycemia & hyperglycemia is expected to drive the market growth.

The Latin America continuous glucose monitoring device market was valued at US$ 126.2 million in 2018 and is expected to witness a CAGR of 15.9% during the forecast period (2018– 2026).

Figure 1. Latin America Continuous Glucose Monitoring Device Market Share (%), By Component

Latin America Continuous Glucose Monitoring Device  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increasing initiative by key players for distribution of continuous monitoring device in Latin America is expected to boost growth of Latin America continuous glucose monitoring device market

Major players are adopting inorganic growth strategies such as collaboration, in order to distribute their products in Latin America and increase their market share in the region. For instance, in February 2019, Senseonics Holdings, Inc. announced expansion of distribution agreement with Roche Diabetes Care by providing them with exclusive distribution rights, for distribution of implantable continuous glucose monitoring (CGM) system, in 17 countries including Brazil, Russia, India, and China as well as selected markets in the Asia Pacific and Latin American regions.

Moreover, increasing product launches by key players also contribute to growth of Latin America continuous glucose monitoring device market. Insulin pumps segment is expected to witness significant growth over the forecast period, owing to increasing product launches of insulin pumps for continuous glucose monitoring. For instance, in March 2019, Medtronic Plc. launched MiniMed 670G system, a self-adjusting insulin pump system for patients who have type 1 diabetes, in the U.K. Medtronic Plc. also supplies diabetic care products in Latin American countries such as Brazil, Chile, Colombia, and others.

However, high cost of continuous glucose monitoring devices is expected to hinder the Latin America continuous glucose monitoring device market growth. A CGM system is more expensive than using a standard glucose meter due to the sensors integrated in this system. These sensors have very short life span such as 7- 14 days and it requires continuous replacement. Thus, it may lead to high cost of the device throughout the treatment due to repetitive replacement, which may lower the user acceptance towards this device.

Latin America Continuous Glucose Monitoring Device Market – Country-wise Analysis

On the basis of country-wise segmentation, Latin America continuous glucose monitoring device market is segmented into Mexico, Argentina, Uruguay, Brazil, Colombia, Chile, Peru and Rest of Latin America.

Brazil is expected to grow at a faster pace and account for the largest market share in Latin America continuous glucose monitoring device market over the forecast period, owing to product launches in the countries. For instance, in February 2019, Abbott launched their continuous glucose monitoring system, FreeStyle LibreLink.

Mexico continuous glucose monitoring device market is expected to witness significant growth over the forecast period, owing to launch of continuous glucose monitoring devices in Mexico. For instance, in October 2017, Abbott introduced its FreeStyle Libre system in Mexico. Moreover, according to Mexican Federation of Diabetes AC, in 2017, around 9.4% of the population in Mexico was diagnosed with diabetes.

Moreover, increasing healthcare expenditure in Latin American countries such as Argentina, Colombia, Chile, and Peru is expected to boost the market growth. According to the World Health Organization (WHO), Colombia has the best and high quality healthcare system among all the Latin American countries. Moreover, increasing healthcare expenditure in Argentina is expected to aid in significant market growth. For instance, according to the World Bank, in 2014, the total health expenditure in Argentina was reported as 76.57% of the total GDP (US$ 526.32 Billion).

Figure 2: Latin America Continuous Glucose Monitoring Device Market Share (%), By Region

Latin America Continuous Glucose Monitoring Device  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Latin America Continuous Glucose Monitoring Device Market- Competitive Landscape

Key players operating in Latin America continuous glucose monitoring device market include Medtronic Plc, Abbott, F. Hoffmann-La Roche AG, Johnson & Johnson, Senseonics, Inc, Dexcom, Inc., Insulet Corporation, and Tandem Diabetes Care, Inc.

Continuous glucose monitoring devices are considered as significant systems for improving diabetes management by providing better and pain-free blood glucose measurement. Continuous glucose monitoring devices marked a remarkable change in diabetes care, as these devices provide real-time information on blood glucose levels, non-invasively than conventional glucose monitoring devices. Continuous glucose monitoring devices constantly tracks the blood glucose level throughout the day. This device consists of various components such as sensors, transmitters, and receivers for measuring and analyzing the glucose levels.

Market Dynamics

Latin America continuous glucose monitoring device market is expected to witness significant growth over the forecast period, owing to increasing incidence of diabetes in Latin American countries which may result in increasing demand for continuous glucose monitoring device in this region. For instance, according to Global Burden of Disease Study 2016, the incidence rate of diabetes in Latin America increased from 2.74% in 2010 to 3.06% in 2016. Among all countries in Latin America, diabetes affects large number of adult population based in Mexico and Brazil.

Furthermore, convenience offered by continuous glucose monitoring devices such as display of glucose trend graph and direction arrows that allow diabetic patients to anticipate approaching glucose highs and lows regularly throughout the day, may increase the demand for these devices, which in turn is expected to drive the market growth. Moreover, technological advancements in continuous glucose monitoring components such as use of sensor with long life expectancy in continuous monitoring devices that eliminates the repetitive replacement of sensors is expected to generate remarkable revenue in the market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of Latin America continuous glucose Monitoring Device Market device market size (US$ Mn) and compound annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in Latin America continuous glucose monitoring device market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Medtronic Plc, Abbott, F. Hoffmann-La Roche AG, Johnson & Johnson, Senseonics, Inc, Dexcom, Inc., Insulet Corporation, and Tandem Diabetes Care, Inc
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • Latin America continuous glucose monitoring device market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for anesthesia device market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Latin America Continuous Glucose Monitoring Device Market , By Component:
    • Transmitters
    • Receivers
    • Insulin Pumps
    • Sensors
  • Latin America Continuous Glucose Monitoring Device Market , By Distribution Channel:
    • Hospitals & Clinics
    • Retail Channel
    • Online Channel
  • Latin America Continuous Glucose Monitoring Device Market , By Country:
    • Mexico
      • By Components
        • Transmitters
        • Receivers
        • Insulin Pumps
        • Sensors
      • By Distribution Channels:
        • Hospitals & Clinics
        • Retail Channel
        • Online Channel
    • Argentina
      • By Components
        • Transmitters
        • Receivers
        • Insulin Pumps
        • Sensors
      • By Distribution Channels:
        • Hospitals & Clinics
        • Retail Channel
        • Online Channel
    • Uruguay
      • By Components
        • Transmitters
        • Receivers
        • Insulin Pumps
        • Sensors
      • By Distribution Channels:
        • Hospitals & Clinics
        • Retail Channel
        • Online Channel
    • Brazil
      • By Components
        • Transmitters
        • Receivers
        • Insulin Pumps
        • Sensors
      • By Distribution Channels:
        • Hospitals & Clinics
        • Retail Channel
        • Online Channel
    • Colombia
      • By Components
        • Transmitters
        • Receivers
        • Insulin Pumps
        • Sensors
      • By Distribution Channels:
        • Hospitals & Clinics
        • Retail Channel
        • Online Channel
    • Chile
      • By Components
        • Transmitters
        • Receivers
        • Insulin Pumps
        • Sensors
      • By Distribution Channels:
        • Hospitals & Clinics
        • Retail Channel
        • Online Channel
    • Peru
      • By Components
        • Transmitters
        • Receivers
        • Insulin Pumps
        • Sensors
      • By Distribution Channels:
        • Hospitals & Clinics
        • Retail Channel
        • Online Channel
    • Rest of Latin America
      • By Components
        • Transmitters
        • Receivers
        • Insulin Pumps
        • Sensors
      • By Distribution Channels:
        • Hospitals & Clinics
        • Retail Channel
        • Online Channel
  • Company Profiles
      • Medtronic Plc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Abbott
      • F. Hoffmann-La Roche AG.
      • Johnson & Johnson
      • Senseonics, Inc
      • Dexcom, Inc.
      • Insulet Corporation
      • Tandem Diabetes Care, Inc

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Component
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Country
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Regulatory Scenario
    • PORTER’S Five Forces
    • PEST Analysis
  4. Latin America Continuous Glucose Monitoring Device Market, By Component, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Transmitters
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Receivers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Insulin Pumps
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Sensors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  5. Latin America Continuous Glucose Monitoring Device Market, By Distribution Channel, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospital & Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Retail Channel
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Online Channel
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  6. Latin America Continuous Glucose Monitoring Device Market, By Country, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Country, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, By Country, 2017 – 2026
      • Country Wise Trends
    • Mexico
      • Market Size and Forecast, By Component, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
    • Argentina
      • Market Size and Forecast, By Component, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
    • Uruguay
      • Market Size and Forecast, By Component, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
    • Brazil
      • Market Size and Forecast, By Component, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
    • Colombia
      • Market Size and Forecast, By Component, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
    • Chile
      • Market Size and Forecast, By Component, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
    • Peru
      • Market Size and Forecast, By Component, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
    • Rest of Latin America
      • Market Size and Forecast, By Component, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
  7. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Medtronic Plc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Abbott
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • F. Hoffmann-La Roche AG.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Senseonics, Inc
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Dexcom, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Insulet Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Tandem Diabetes Care, Inc
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 33 market data tables and 23 figures on “Latin America Continuous Glucose Monitoring Device Market” – Country Specific forecast to 2026”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.